Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients
The DOI matches its Crossref record.
Abstract
Paroxetine is a new compound in the group of the selective serotonin-reuptake inhibitors. The results of several open and double-blind control-group studies demonstrate clear antidepressive efficacy of paroxetine. However, most data were collected in samples of outpatients. To overcome this restriction, a six-week double-blind control-group study, comparing 30 mg paroxetine with 150mg amitriptyline per day, was performed in a sample of inpatients suffering from major depression. Generally speaking, the efficacy analysis of 160 patients was not able to demonstrate statistically significant differences in the antidepressive activity of paroxetine or amitriptyline, either with respect to the total score on the Hamilton Depression Scale (HAMD) and the Clinical Global Impressions or with respect to the subscores of the HAMD. One exception was the retardation subscore, in which amitriptyline showed a greater degree of reduction. Both drugs had a characteristic side-effect profile. Paroxetine was characterized by a lack of anticholinergic side-effects and a higher rate of nausea. Zusammenfassung Paroxetin ist eine neue Substanz aus der Gruppe der selektiven Serotoninwiederaufhahmehemmer. Die Ergebnisse verschiedener offener und doppelblinder Kontrollgruppenstudien zeigen einen klaren antidepressiven Effekt. Die meisten Studien wurden allerdings an ambulanten Patienten durchgeführt. Um diese Einschränkung zu beheben, wurden in einer 6 Wochen dauernden Kontrollgruppenstudie 30 mg Paroxetin mit 150 mg Amitriptylin per die in einer Stichprobe von stationär behandelten Patienten mit "major depression" verglichen. Die Effektivitätsanalyse an 160 Patienten konnte insgesamt keine statistisch signifikanten Unterschiede der antidepressiven Wirksamkeit von Paroxetin im Vergleich zu Amitriptylin, weder auf der Ebene des Hamilton-Gesamtscores und der klinischen Gesamtbeurteilung noch hinsichtlich der Subscores der Hamilton-Depressions-Skala, aufzeigen. Lediglich der Subscore "retardation" zeigte unter Amitriptylin eine stärkergradige Reduktion. Beide Substanzen haben ein charakteristisches Nebenwirkungsprofil. Typisch für Paroxetin sind das Fehlen anticholinerger Nebenwirkungen und eine höhere Häufigkeit von Nausea.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Bourin, M., Chue, P., & Guillon, Y. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00189.x · Cited by 408
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
“One criticism of this study is what is considered as a relatively low dose of paroxetine (20 mg/day), whereas clinically effective doses in unipolar depression are in the range of 30-40 mg/day (Dunner and Dunbar 1992; Möller et al. 1993).”
BackgroundSelf-citationAnderson, I. M., & Tomenson, B. M. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 306
Metadata
- Authors
- Möller, H., Berzewski, H., Eckmann, F., Gonzalves, N., Kissling, W., Knorr, W., Ressler, P., Rudolf, G., Steinmeyer, E., Magyar, I., Szucs, R., & Szilard, J.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 1993-05
- Volume
- 26
- Issue
- 03
- Pages
- 75-78
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2016865081
- Cited by
- 47
- References
- 0
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients. https://app.cochat.ai/papers/10.1055/s-2007-1014346
- The paper
- Möller, H., Berzewski, H., Eckmann, F., Gonzalves, N., Kissling, W., Knorr, W., Ressler, P., Rudolf, G., Steinmeyer, E., Magyar, I., Szucs, R., & Szilard, J. (1993). Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients. Pharmacopsychiatry. https://doi.org/10.1055/s-2007-1014346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.